What are the possible complications of laser peripheral iridotomy (LPI)?

Answer

Complications of laser peripheral iridotomy include postoperative IOP spike, intraocular inflammation, iris bleeding and hyphema, focal cataract,^[9]posterior synechiae, visual symptoms (eg, blurred vision, haloes, lines, glare, and diplopia), corneal decompensation, and miscellaneous complications.

Did this answer your question?

Yes No

Additional feedback? (Optional)

Thank you for your feedback!

Robin AL, Eliassi-Rad B. Laser Iridotomy. Morrison JC, Pollack IP. Glaucoma: Science and Practice. New York, NY: Thieme; 2003. (41)439-445.
Lam DSC, Tham CCY, Congdon N. Peripheral iridotomy for angle-closure glaucoma. Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG. Glaucoma. China: Saunders; 2009. Vol 2: (65)61-69.
Harsh Kumar, Tarannum Mansoori, Gazella B Warjri, Bindu I Somarajan, Suman Bandil, Viney Gupta. Lasers in Glaucoma. Indian Journal of Ophthalmology. 10-25-2018. 66:1539-1553. [Medline]. [Full Text].
Abraham RK, Munnerly C. Laser iridotomy. Improved methodology with a new iridotomy lens. Ophthalmology. 1979. 86 (suppl):126.
Robin AL, Pollack IP, deFaller JM. Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy. Arch Ophthalmol. 1987 Sep. 105(9):1208-11. [Medline].
Rosenberg LF, Krupin T, Ruderman J, et al. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise. Ophthalmology. 1995 Sep. 102(9):1312-8. [Medline].
Chen TC, Ang RT, Grosskreutz CL, Pasquale LR, Fan JT. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery. Ophthalmology. 2001 Jun. 108(6):1033-8. [Medline].
Fleck BW. How large must an iridotomy be?. Br J Ophthalmol. 1990 Oct. 74(10):583-8. [Medline].
Vijaya L, Asokan R, Panday M, George R. Is prophylactic laser peripheral iridotomy for primary angle closure suspects a risk factor for cataract progression? The Chennai Eye Disease Incidence Study. Br J Ophthalmol. 2017 May. 101 (5):665-670. [Medline].
Moster MR, Schwartz LW, Spaeth GL, et al. Laser iridectomy. A controlled study comparing argon and neodymium: YAG. Ophthalmology. 1986 Jan. 93(1):20-4. [Medline].
Pollack IP, Robin AL, Dragon DM, Green WR, Quigley HA, Murray TG. Use of the neodymium:YAG laser to create iridotomies in monkeys and humans. Trans Am Ophthalmol Soc. 1984. 82:307-28. [Medline].
Krupin T, Stone RA, Cohen BH, Kolker AE, Kass MA. Acute intraocular pressure response to argon laser iridotomy. Ophthalmology. 1985 Jul. 92(7):922-6. [Medline].
Ritch R, Liebmann JM. Laser iridotomy and peripheral iridoplasty. Ritch R, Shields MB, Krupin T. The Glaucomas. 2nd. St. Louis, MO: CV Mosby; 1996. Vol 3: (76)1549-64.
McAllister JA, Schwartz LW, Moster M, Spaeth GL. Laser peripheral iridectomy comparing Q-switched neodymium YAG with argon. Trans Ophthalmol Soc U K. 1985. 104 ( Pt 1):67-9. [Medline].
Gilbert CM, Robin AL, Pollack IP. Iridotomy using the Q-switched neodymium (Nd):YAG laser. Ophthalmology. 1984 Sep. 91(9):1123. [Medline].
Lederer CM Jr, Price PK. Posterior synechiae after laser iridectomy. Ann Ophthalmol. 1989 Feb. 21(2):61-4. [Medline].
Spaeth GL, Idowu O, Seligsohn A, et al. The effects of iridotomy size and position on symptoms following laser peripheral iridotomy. J Glaucoma. 2005 Oct. 14(5):364-7. [Medline].
Srinivasan K, Zebardast N, Krishnamurthy P, Abdul Kader M, Raman GV, Rajendrababu S, et al. Comparison of New Visual Disturbances after Superior versus Nasal/Temporal Laser Peripheral Iridotomy: A Prospective Randomized Trial. Ophthalmology. 2018 Mar. 125 (3):345-351. [Medline].
Kavitha, Srinivasan et al. Resolution of Visual Dysphotopsias after Laser Iridotomy: Six-Month Follow-up. Ophthalmology. March 2019. 126:469-71. [Full Text].
Wishart PK, Sherrard ES, Nagasubramanian S, Kerr Muir MG, Hitchings RA. Corneal endothelial changes following short pulsed laser iridotomy and surgical iridectomy. Trans Ophthalmol Soc U K. 1986. 105 ( Pt 5):541-8. [Medline].
Schwartz AL, Martin NF, Weber PA. Corneal decompensation after argon laser iridectomy. Arch Ophthalmol. 1988 Nov. 106(11):1572-4. [Medline].
Small KM, Maslin KF. Malignant glaucoma following laser iridotomy. Aust N Z J Ophthalmol. 1995 Nov. 23(4):339-41. [Medline].
Obana A, Gohto Y, Ueda N, et al. Retinal and subhyaloid hemorrhage as a complication of laser iridectomy for primary angle-closure glaucoma. Arch Ophthalmol. 2000 Oct. 118(10):1449-51. [Medline].
Corriveau LA, Nasr Y, Fanous S. Choroidal and retinal detachment following argon laser iridotomy. Can J Ophthalmol. 1986 Apr. 21(3):107-8. [Medline].
Anderson JE, Gentile RC, Sidoti PA, Rosen RB. Stage 1 macular hole as a complication of laser iridotomy. Arch Ophthalmol. 2006 Nov. 124(11):1658-60. [Medline].
Baskaran M, Yang E, Trikha S, Kumar RS, Wong HT, He M, et al. Residual Angle Closure One Year After Laser Peripheral Iridotomy in Primary Angle Closure Suspects. Am J Ophthalmol. 2017 Nov. 183:111-117. [Medline].

Media Gallery

Argon laser.
Neodymium:yttrium-aluminum-garnet (Nd:YAG) laser.
Abraham iridotomy lens.
Pascal laser.

of 4

Author

Frank X Cao, MD Attending Ophthalmologist (Glaucoma), Millman-Derr Center for Eye Care

Frank X Cao, MD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, American Medical Association, American Society of Cataract and Refractive Surgery

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Chief Editor

C Stephen Foster, MD, FACS, FACR, FAAO, FARVO Clinical Professor of Ophthalmology, Harvard Medical School; Consulting Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary; Founder and President, Ocular Immunology and Uveitis Foundation, Massachusetts Eye Research and Surgery Institution

C Stephen Foster, MD, FACS, FACR, FAAO, FARVO is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Association of Immunologists, American College of Rheumatology, American College of Surgeons, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, American Uveitis Society, Association for Research in Vision and Ophthalmology, Massachusetts Medical Society, Royal Society of Medicine, Sigma Xi

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Aldeyra Therapeutics (Lexington, MA); Bausch & Lomb Surgical, Inc (Rancho Cucamonga, CA); Eyegate Pharma (Waltham, MA); Novartis (Cambridge, MA); pSivida (Watertown, MA); Xoma (Berkeley, CA); Allakos (Redwood City, CA)<br/>Serve(d) as a speaker or a member of a speakers bureau for: Alcon (Geneva, Switzerland); Allergan (Dublin, Ireland); Mallinckrodt (Staines-upon-Thames, United Kingdom)<br/>Received research grant from: Alcon; Aldeyra Therapeutics; Allakos Pharmaceuticals; Allergan; Bausch & Lomb; Clearside Biomedical; Dompé pharmaceutical; Eyegate Pharma; Mallinckrodt pharmaceuticals; Novartis; pSivida; Santen; Aciont.

Additional Contributors

Babak Eliassi-Rad, MD Assistant Professor, Director of Glaucoma Service, Department of Ophthalmology, Boston University School of Medicine

Babak Eliassi-Rad, MD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society

Disclosure: Nothing to disclose.

What are the possible complications of laser peripheral iridotomy (LPI)?

Answer

Related Questions:

References

Tables

Contributor Information and Disclosures